Dopamine
- Formula
- C8H11NO2
- Molecular Weight
- 153.18 g/mol
- Aliases
- 3,4-Dihydroxyphenethylamine, DA
Pharmacological Mechanism
catecholamine synthesis synthesised from tyrosine via L-DOPA (tyrosine hydroxylase, rate-limiting) → dopamine (AADC). Acts at dopamine receptor signaling D1-like (D1, D5) and D2-like (D2, D3, D4) GPCRs. Nigrostriatal pathway → motor control; mesolimbic → reward; mesocortical → executive function; tuberoinfundibular → prolactin suppression. Depleted in Parkinson's (nigrostriatal loss).
Dosing Guidelines
- Intravenous (IV): Typical 8 mcg (Range: 2–20 mcg)
Pathways It Modulates
Target Organ Systems
Interactions
- Levodopa (synergistic): L-DOPA is the BBB-crossing precursor; converted to dopamine by AADC in CNS and periphery.
- Tyrosine (synergistic): Dietary precursor via tyrosine hydroxylase (rate-limiting).
- Norepinephrine (synergistic): Upstream catecholamine precursor via DβH.
Chemical Structure & Identifiers
- InChIKey: VYFYYTLLBUKUHU-UHFFFAOYSA-N
- SMILES: C1=CC(=C(C=C1CCN)O)O